589 related articles for article (PubMed ID: 10936974)
1. Clinical trial to evaluate immunogenicity and safety of inactivated hepatitis A vaccination starting at 2-month-old children.
Kanra G; Yalçin SS; Ceyhan M; Yurdakök K
Turk J Pediatr; 2000; 42(2):105-8. PubMed ID: 10936974
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and safety of an inactivated hepatitis A vaccine in Taiwanese adults and children.
Lee CY; Huang LM; Lee PI; Chiu HH; Dumas R; Milcamps B; Lin W
Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):29-36. PubMed ID: 11023061
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity, safety, and interchangeability of two inactivated hepatitis A vaccines in Chilean children.
Abarca K; Ibánez I; Perret C; Vial P; Zinsou JA
Int J Infect Dis; 2008 May; 12(3):270-7. PubMed ID: 17988917
[TBL] [Abstract][Full Text] [Related]
4. A trial of the reactogenicity and immunogenicity of an inactivated hepatitis A vaccine.
Green MS; Cohen D; Lerman Y; Sjogren M; Binn LN; Zur S; Slepon R; Robin G; Hoke C; Bancroft W
Isr J Med Sci; 1994; 30(5-6):485-8. PubMed ID: 8034508
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of a new inactivated hepatitis A vaccine in Thai young adults.
Vimolket T; Theamboonlers A; Dumas R; Milcamps B; Forrat R; Poovorawan Y
Southeast Asian J Trop Med Public Health; 1998 Dec; 29(4):779-85. PubMed ID: 10772564
[TBL] [Abstract][Full Text] [Related]
6. Immunogenicity and safety of an inactivated hepatitis A vaccine amongst Singaporeans.
Guan R; Ng HS; Fock KM; Ho KY; Yap I; Kang JY; Chow WC; Chew CN; Ng C; Teo CJ
Southeast Asian J Trop Med Public Health; 1995 Jun; 26(2):268-71. PubMed ID: 8629058
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of immunogenicity and safety in healthy adults of an inactivated anti-hepatitis A vaccine].
Gil A; González A; Dal-Ré ; Aguilar L; Malo C; del Rey J
Med Clin (Barc); 1994 May; 102(20):769-71. PubMed ID: 8041214
[TBL] [Abstract][Full Text] [Related]
8. [The study on the 0, 12 month vaccination schedule' of Healive inactivated hepatitis A vaccine in children].
Ren YH; Chen JT; Wu WT; Gong XJ; Zhang YC; Xue WH; Ren YF; Han LJ; Kang WX; Li SP; Liu CB
Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Nov; 24(11):1013-5. PubMed ID: 14687502
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity and safety of three consecutive lots of a new preservative-free inactivated hepatitis A vaccine (Healive): a double-blind, randomized and controlled trial.
Jiang WP; Chen JT; Wang X; Wang YL; Liu Y; Chen WY; Xu WG; Qiu YZ; Yin WD
Vaccine; 2008 Apr; 26(18):2297-301. PubMed ID: 18395305
[TBL] [Abstract][Full Text] [Related]
10. Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults.
Van Damme P; Leroux-Roels G; Law B; Diaz-Mitoma F; Desombere I; Collard F; Tornieporth N; Van Herck K
J Med Virol; 2001 Sep; 65(1):6-13. PubMed ID: 11505437
[TBL] [Abstract][Full Text] [Related]
11. Single dose-inactivated hepatitis A vaccination schedule for susceptible youngsters.
Lee SD; Chan CY; Yu MI; Wang YJ; Lo KJ; Safary A
Am J Gastroenterol; 1996 Jul; 91(7):1360-2. PubMed ID: 8677995
[TBL] [Abstract][Full Text] [Related]
12. [Reactivity and immunogenicity of Havrix 360 vaccine for hepatitis A].
Borcić B; Kovac S; Mihaljević I; Dobrovsak-Sourek V; Ljubicić M
Lijec Vjesn; 1996; 118(7-8):162-4. PubMed ID: 8965633
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity and reactogenicity of an inactivated hepatitis A vaccine in Indian adults.
Das K; Jain A; Gupta RK; Kar P
Natl Med J India; 1999; 12(6):268-9. PubMed ID: 10732428
[TBL] [Abstract][Full Text] [Related]
14. [A comparative study on safety and immunogenicity of an inactivated hepatitis A vaccine in HBsAg carriers and healthy children].
Chen J; Ren Y; Wu W; Ma S; Li S; Wang J; Kang W; Han L; Gao S; Zhang Y; Liu C
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2002 Dec; 16(4):380-1. PubMed ID: 12665912
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and efficacy of a killed hepatitis A vaccine in day care center children.
Richtmann R; Chaves RL; Mendonça JS; Konichi SR; Mitre HP; Takei K; Dietz K; Flehmig B
J Med Virol; 1996 Feb; 48(2):147-50. PubMed ID: 8835347
[TBL] [Abstract][Full Text] [Related]
16. Mathematical models for assessment of long-term persistence of antibodies after vaccination with two inactivated hepatitis A vaccines.
Van Herck K; Beutels P; Van Damme P; Beutels M; Van den Dries J; Briantais P; Vidor E
J Med Virol; 2000 Jan; 60(1):1-7. PubMed ID: 10568755
[TBL] [Abstract][Full Text] [Related]
17. [Safety and immunogenicity of a new inactivated hepatitis A vaccine].
Ren A; Ma J; Feng F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2001 Dec; 15(4):357-9. PubMed ID: 11986726
[TBL] [Abstract][Full Text] [Related]
18. Immunization of seronegative infants with hepatitis A vaccine (HAVRIX; SKB): a comparative study of two dosing schedules.
Troisi CL; Hollinger FB; Krause DS; Pickering LK
Vaccine; 1997 Oct; 15(15):1613-7. PubMed ID: 9364691
[TBL] [Abstract][Full Text] [Related]
19. Safety and immunogenicity of live attenuated hepatitis A virus vaccine (H2 strain) in humans.
Ran LA; Wang DZ; Duan QY; Yan TY; Liu QL; Luo YG; Yang DZ; Yang DF; Xiao Z; Xie QJ
Chin Med J (Engl); 1993 Aug; 106(8):604-7. PubMed ID: 8222910
[TBL] [Abstract][Full Text] [Related]
20. [Protection of adolescents against hepatitis A].
Puntarić D; Baklaić Z; Ljubicíc M; Vodopija I
Lijec Vjesn; 1996 Oct; 118(10):241-3. PubMed ID: 9132523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
